» Articles » PMID: 32669338

A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat

Overview
Journal J Virol
Date 2020 Jul 17
PMID 32669338
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The magnitude of transcription factor binding site variation emerging in HIV-1 subtype C (HIV-1C), especially the addition of NF-κB motifs by sequence duplication, makes the examination of transcriptional silence challenging. How can HIV-1 establish and maintain latency despite having a strong long terminal repeat (LTR)? We constructed panels of subgenomic reporter viral vectors with varying copy numbers of NF-κB motifs (0 to 4 copies) and examined the profile of latency establishment in Jurkat cells. Surprisingly, we found that the stronger the viral promoter, the faster the latency establishment. Importantly, at the time of commitment to latency and subsequent points, Tat levels in the cell were not limiting. Using highly sensitive strategies, we demonstrate the presence of Tat in the latent cell, recruited to the latent LTR. Our data allude, for the first time, to Tat establishing a negative feedback loop during the late phases of viral infection, leading to the rapid silencing of the viral promoter. Over the past 10 to 15 years, HIV-1 subtype C (HIV-1C) has been evolving rapidly toward gaining stronger transcriptional activity by sequence duplication of major transcription factor binding sites. The duplication of NF-κB motifs is unique and exclusive to HIV-1C, a property not shared with any of the other eight HIV-1 genetic families. What mechanism(s) does HIV-1C employ to establish and maintain transcriptional silence despite the presence of a strong promoter and concomitant strong, positive transcriptional feedback is the primary question that we attempted to address in the present manuscript. The role that Tat plays in latency reversal is well established. Our work with the most common HIV-1 subtype, HIV-1C, offers crucial leads toward Tat possessing a dual role in serving as both a transcriptional activator and repressor at different phases of viral infection of the cell. The leads that we offer through the present work have significant implications for HIV-1 cure research.

Citing Articles

Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal.

Maikoo S, Palstra R, Dong K, Mahmoudi T, Ndungu T, Madlala P J Virus Erad. 2025; 10(4):100575.

PMID: 39811575 PMC: 11730875. DOI: 10.1016/j.jve.2024.100575.


Proximity Ligation Assay to Detect the Proximity Between Host Proteins and Viral Proteins of HIV-1.

Chakraborty S, Suresh S, Buch H, Panchapakesan A, Ranga U Methods Mol Biol. 2024; 2807:245-258.

PMID: 38743233 DOI: 10.1007/978-1-0716-3862-0_17.


Experimental models for HIV latency and molecular tools for reservoir quantification-an update.

Angamuthu D, Vivekanandan S, Hanna L Clin Microbiol Rev. 2023; 36(4):e0001323.

PMID: 37966222 PMC: 10732067. DOI: 10.1128/cmr.00013-23.


Transcriptional Stochasticity as a Key Aspect of HIV-1 Latency.

Damour A, Slaninova V, Radulescu O, Bertrand E, Basyuk E Viruses. 2023; 15(9).

PMID: 37766375 PMC: 10535884. DOI: 10.3390/v15091969.


Enhanced Transcriptional Strength of HIV-1 Subtype C Minimizes Gene Expression Noise and Confers Stability to the Viral Latent State.

Pal S, Jaiswal V, Nala N, Ranga U J Virol. 2022; 97(1):e0137622.

PMID: 36533949 PMC: 9888270. DOI: 10.1128/jvi.01376-22.


References
1.
Weinberger L, Shenk T . An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer. PLoS Biol. 2006; 5(1):e9. PMC: 1717016. DOI: 10.1371/journal.pbio.0050009. View

2.
van Zyl G, Bale M, Kearney M . HIV evolution and diversity in ART-treated patients. Retrovirology. 2018; 15(1):14. PMC: 5789667. DOI: 10.1186/s12977-018-0395-4. View

3.
Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G . Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol. 1999; 19(8):5504-11. PMC: 84392. DOI: 10.1128/MCB.19.8.5504. View

4.
Sanders R, Clark C, Morello C, Spector D . Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses. J Virol. 2008; 82(14):7059-77. PMC: 2446980. DOI: 10.1128/JVI.00675-08. View

5.
Banaszynski L, Chen L, Maynard-Smith L, Ooi A, Wandless T . A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell. 2006; 126(5):995-1004. PMC: 3290523. DOI: 10.1016/j.cell.2006.07.025. View